| Promacta (eltrombopag) / Novartis |
NCT04518878: Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER) |
|
|
| Recruiting | 1 | 30 | RoW | Eltrombopag, Revolade, rhTPO, TPIAO, tebiao | Peking University People's Hospital | Immune Thrombocytopenia | 12/21 | 06/22 | | |
NCT05924152: A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib |
|
|
| Completed | 1 | 16 | US | Adagrasib, Eltrombopag + adagrasib | Mirati Therapeutics Inc. | Healthy Adults | 08/23 | 08/23 | | |
| Active, not recruiting | 1 | 20 | US | Rosuvastatin, Crestor, Rosuvastatin (Inhibitor arm), Cresto, Eltrombopag, Promacta | University of California, San Francisco, Food and Drug Administration (FDA) | Healthy Volunteers | 12/24 | 12/24 | | |
ChiCTR2200058259: Evaluation of clinical efficacy of low-dose corticosteroid combined with low-dose eltrombopag in newly diagnosed immune thrombocytopenia: a non-randomized controlled study |
|
|
| Not yet recruiting | 1 | 68 | | Low-dose corticosteroid combined with low-dose eltrombopag ;Regular-dose dexamethasone or prednisone | Zhejiang Provincial Hospital of Traditional Chinese Medicine; Zhejiang Provincial Hospital of Traditional Chinese Medicine, Self-funded, National Key Disciplines Funding | Immune Thrombocytopenia (ITP) | | | | |
CCPO011, NCT04485416: Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors |
|
|
| Recruiting | 1 | 10 | US | Eltrombopag, Promacta | Anjali Pawar | Solid Tumor, Childhood, Solid Tumor | 12/24 | 12/24 | | |
